The influence of 4G/5G polymorphism in the plasminogen-activator-inhibitor-1 promoter on COVID-19 severity and endothelial dysfunction.
Saved in:
| Title: | The influence of 4G/5G polymorphism in the plasminogen-activator-inhibitor-1 promoter on COVID-19 severity and endothelial dysfunction. |
|---|---|
| Authors: | Yatsenko T; Department of Research Support Utilizing Bioresource Bank, Graduate School of Medicine, Juntendo University, Tokyo, Japan.; Department of Enzymes Chemistry and Biochemistry, Palladin Institute of Biochemistry of National Academy of Sciences of Ukraine, Kyiv, Ukraine., Rios R; Institute of Computing, Federal University of Bahia, Salvador, Bahia, Brazil., Nogueira T; Institute of Computing, Federal University of Bahia, Salvador, Bahia, Brazil., Salama Y; An-Najah Center for Cancer and Stem Cell Research, Faculty of Medicine and Health Sciences, An-Najah National University, Nablus, Palestine., Takahashi S; Division of Clinical Precision Research Platform, the Institute of Medical Science, the University of Tokyo, Tokyo, Japan., Adachi E; Department of Infectious Diseases and Applied Immunology, the Institute of Medical Science, the University of Tokyo, Tokyo, Japan., Tabe Y; Department of Research Support Utilizing Bioresource Bank, Graduate School of Medicine, Juntendo University, Tokyo, Japan., Hattori N; Center for Genome and Regenerative Medicine, Juntendo University, Graduate School of Medicine, Tokyo, Japan., Osada T; Department of Gastroenterology, Juntendo University, Urayasu Hospital, Urayasu-shi, Japan., Naito T; Department of Research Support Utilizing Bioresource Bank, Graduate School of Medicine, Juntendo University, Tokyo, Japan., Takahashi K; Department of Research Support Utilizing Bioresource Bank, Graduate School of Medicine, Juntendo University, Tokyo, Japan., Hattori K; Center for Genome and Regenerative Medicine, Juntendo University, Graduate School of Medicine, Tokyo, Japan.; Department of Hematology/Oncology, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan., Heissig B; Department of Research Support Utilizing Bioresource Bank, Graduate School of Medicine, Juntendo University, Tokyo, Japan. |
| Source: | Frontiers in immunology [Front Immunol] 2024 Aug 30; Vol. 15, pp. 1445294. Date of Electronic Publication: 2024 Aug 30 (Print Publication: 2024). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Links: – Type: pdflink Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 39281671 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: The influence of 4G/5G polymorphism in the plasminogen-activator-inhibitor-1 promoter on COVID-19 severity and endothelial dysfunction. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Yatsenko+T%22">Yatsenko T</searchLink>; Department of Research Support Utilizing Bioresource Bank, Graduate School of Medicine, Juntendo University, Tokyo, Japan.; Department of Enzymes Chemistry and Biochemistry, Palladin Institute of Biochemistry of National Academy of Sciences of Ukraine, Kyiv, Ukraine.<br /><searchLink fieldCode="AU" term="%22Rios+R%22">Rios R</searchLink>; Institute of Computing, Federal University of Bahia, Salvador, Bahia, Brazil.<br /><searchLink fieldCode="AU" term="%22Nogueira+T%22">Nogueira T</searchLink>; Institute of Computing, Federal University of Bahia, Salvador, Bahia, Brazil.<br /><searchLink fieldCode="AU" term="%22Salama+Y%22">Salama Y</searchLink>; An-Najah Center for Cancer and Stem Cell Research, Faculty of Medicine and Health Sciences, An-Najah National University, Nablus, Palestine.<br /><searchLink fieldCode="AU" term="%22Takahashi+S%22">Takahashi S</searchLink>; Division of Clinical Precision Research Platform, the Institute of Medical Science, the University of Tokyo, Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Adachi+E%22">Adachi E</searchLink>; Department of Infectious Diseases and Applied Immunology, the Institute of Medical Science, the University of Tokyo, Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Tabe+Y%22">Tabe Y</searchLink>; Department of Research Support Utilizing Bioresource Bank, Graduate School of Medicine, Juntendo University, Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Hattori+N%22">Hattori N</searchLink>; Center for Genome and Regenerative Medicine, Juntendo University, Graduate School of Medicine, Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Osada+T%22">Osada T</searchLink>; Department of Gastroenterology, Juntendo University, Urayasu Hospital, Urayasu-shi, Japan.<br /><searchLink fieldCode="AU" term="%22Naito+T%22">Naito T</searchLink>; Department of Research Support Utilizing Bioresource Bank, Graduate School of Medicine, Juntendo University, Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Takahashi+K%22">Takahashi K</searchLink>; Department of Research Support Utilizing Bioresource Bank, Graduate School of Medicine, Juntendo University, Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Hattori+K%22">Hattori K</searchLink>; Center for Genome and Regenerative Medicine, Juntendo University, Graduate School of Medicine, Tokyo, Japan.; Department of Hematology/Oncology, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Heissig+B%22">Heissig B</searchLink>; Department of Research Support Utilizing Bioresource Bank, Graduate School of Medicine, Juntendo University, Tokyo, Japan. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101560960%22">Frontiers in immunology</searchLink> [Front Immunol] 2024 Aug 30; Vol. 15, pp. 1445294. <i>Date of Electronic Publication: </i>2024 Aug 30 (<i>Print Publication: </i>2024). – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Frontiers+Research+Foundation]%22">Frontiers Research Foundation] </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>101560960 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Internet <i>ISSN: </i>1664-3224 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2216643224%22">16643224 </searchLink><i>NLM ISO Abbreviation: </i>Front Immunol <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=39281671 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.3389/fimmu.2024.1445294 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 1445294 Titles: – TitleFull: The influence of 4G/5G polymorphism in the plasminogen-activator-inhibitor-1 promoter on COVID-19 severity and endothelial dysfunction. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Yatsenko T – PersonEntity: Name: NameFull: Rios R – PersonEntity: Name: NameFull: Nogueira T – PersonEntity: Name: NameFull: Salama Y – PersonEntity: Name: NameFull: Takahashi S – PersonEntity: Name: NameFull: Adachi E – PersonEntity: Name: NameFull: Tabe Y – PersonEntity: Name: NameFull: Hattori N – PersonEntity: Name: NameFull: Osada T – PersonEntity: Name: NameFull: Naito T – PersonEntity: Name: NameFull: Takahashi K – PersonEntity: Name: NameFull: Hattori K – PersonEntity: Name: NameFull: Heissig B IsPartOfRelationships: – BibEntity: Dates: – D: 30 M: 08 Text: 2024 Aug 30 Type: published Y: 2024 Identifiers: – Type: issn-electronic Value: 1664-3224 Numbering: – Type: volume Value: 15 Titles: – TitleFull: Frontiers in immunology Type: main |
| ResultId | 1 |
